A visual guide to vaccines for the routine vaccination programme
Updated 1 December 2025
Infanrix hexa or Vaxelis

Infanrix hexa and Vaxelis packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Infanrix hexa (GSK) or Vaxelis (Sanofi Pasteur) Hexavalent vaccine DTaP/IPV/Hib/HepB |
Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | 8, 12 and 16 weeks For children born on or after 01 July 2024, dose 4 at 18 months |
Rotarix

Rotarix packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Rotarix (GSK) Rotavirus (oral) | Rotavirus gastroenteritis | 8 weeks and 12 weeks |
Bexsero

Bexsero packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Bexsero (GSK) MenB | Meningococcal group B | 8 weeks, 12 weeks and 1 year |
Prevenar 13
Prevnar 13 packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Prevenar 13 (Pfizer) PCV | Pneumococcal (13 serotypes) | 16 weeks and 1 year |
Menitorix

Menitorix packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Menitorix (GSK) Hib/MenC | Haemophilus influenzae type b (Hib) and meningococcal group C | 1 year for children born before 30 June 2024 |
ProQuad (MSD) or Priorix Tetra

ProQuad packaging

Priorix-Tetra packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| ProQuad (MSD) or Priorix Tetra (GSK) MMRV |
Measles, mumps, rubella and varicella | Routinely at 1 year and 18 months for children born on or after 1 January 2025 Children born between 1 January 2020 and 31 December 2024 are also eligible for MMRV[footnote 1] |
Boostrix-IPV or REPEVAX

Boostrix-IPV packaging

Repevax packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Boostrix-IPV (GSK) or REPEVAX (Sanofi) dTaP/IPV |
Diphtheria, tetanus, pertussis and polio | 3 years, 4 months |
Gardasil 9
Gardasil packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Gardasil 9 (MSD) HPV | Cancers and genital warts caused by specific human papillomavirus (HPV) types | Boys and girls aged 12 to 13 years (school Year 8) |
REVAXIS
Revaxis packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| REVAXIS (Sanofi Pasteur) Td/IPV | Tetanus, diphtheria and polio | 14 years (school Year 9) |
MenQuadfi
MenQuadfi packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| MenQuadfi (Sanofi) MenACWY | Meningococcal groups A, C, W and Y | 14 years (school Year 9) |
ADACEL
Adacel packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| ADACEL (Sanofi) Tdap | Tetanus, diphtheria and pertussis (whooping cough) | Pregnant women from 16 weeks gestation |
Abrysvo
Abrysyo packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Abrysvo (Pfizer) RSV | Respiratory Syncytial Virus | Pregnant women from 28 weeks gestation 75 years [footnote 2] |
Pneumovax 23 or Prevenar 20

Pneumovax 23 packaging

Prevenar 20 packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Pneumovax 23 (MSD) Pneumococcal polysaccharide vaccine (PPV23) or Prevenar 20 (Pfizer) Pneumococcal conjugate vaccine (PCV20) (once PPV23 no longer available) |
Pneumococcal (23 or 20 serotypes) | 65 years (and certain at-risk groups) [footnote 3] |
Shingrix
Shingrix packaging
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Shingrix (GSK) Shingles | Shingles | 18+ if severely immunosuppressed (no upper age limit) 65 years or 70 years of age [footnote 4] (remain eligible until their 80th birthday) |
Full schedule
Read full details of the routine immunisation schedule.
References
-
The Green Book: Pneumococcal chapter 25 ↩
-
See Shingles: guidance and vaccination programme ↩